These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Halberg RB; Katzung DS; Hoff PD; Moser AR; Cole CE; Lubet RA; Donehower LA; Jacoby RF; Dove WF Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3461-6. PubMed ID: 10716720 [TBL] [Abstract][Full Text] [Related]
3. Localized gene action controlling intestinal neoplasia in mice. Gould KA; Dove WF Proc Natl Acad Sci U S A; 1997 May; 94(11):5848-53. PubMed ID: 9159163 [TBL] [Abstract][Full Text] [Related]
4. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions. Dove WF; Cormier RT; Gould KA; Halberg RB; Merritt AJ; Newton MA; Shoemaker AR Philos Trans R Soc Lond B Biol Sci; 1998 Jun; 353(1370):915-23. PubMed ID: 9684289 [TBL] [Abstract][Full Text] [Related]
5. Generation of a unique strain of multiple intestinal neoplasia (Apc(+/Min-FCCC)) mice with significantly increased numbers of colorectal adenomas. Cooper HS; Chang WC; Coudry R; Gary MA; Everley L; Spittle CS; Wang H; Litwin S; Clapper ML Mol Carcinog; 2005 Sep; 44(1):31-41. PubMed ID: 15937958 [TBL] [Abstract][Full Text] [Related]
6. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice. Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863 [TBL] [Abstract][Full Text] [Related]
7. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Oshima M; Oshima H; Kitagawa K; Kobayashi M; Itakura C; Taketo M Proc Natl Acad Sci U S A; 1995 May; 92(10):4482-6. PubMed ID: 7753829 [TBL] [Abstract][Full Text] [Related]
8. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice. Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247 [TBL] [Abstract][Full Text] [Related]
9. Genetic basis of variation in adenoma multiplicity in ApcMin/+ Mom1S mice. Haines J; Johnson V; Pack K; Suraweera N; Slijepcevic P; Cabuy E; Coster M; Ilyas M; Wilding J; Sieber O; Bodmer W; Tomlinson I; Silver A Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2868-73. PubMed ID: 15710876 [TBL] [Abstract][Full Text] [Related]
10. Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway. Halberg RB; Waggoner J; Rasmussen K; White A; Clipson L; Prunuske AJ; Bacher JW; Sullivan R; Washington MK; Pitot HC; Petrini JH; Albertson DG; Dove WF Cancer Res; 2009 Jul; 69(14):5768-75. PubMed ID: 19584276 [TBL] [Abstract][Full Text] [Related]
11. Analysis of lung tumorigenesis in chimeric mice indicates the Pulmonary adenoma resistance 2 (Par2) locus to operate in the tumor-initiation stage in a cell-autonomous manner: detection of polymorphisms in the Poli gene as a candidate for Par2. Lee GH; Nishimori H; Sasaki Y; Matsushita H; Kitagawa T; Tokino T Oncogene; 2003 Apr; 22(15):2374-82. PubMed ID: 12700672 [TBL] [Abstract][Full Text] [Related]
12. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways. Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ Int J Exp Pathol; 2009 Oct; 90(5):558-74. PubMed ID: 19765110 [TBL] [Abstract][Full Text] [Related]
13. Loss of Apc+ in intestinal adenomas from Min mice. Luongo C; Moser AR; Gledhill S; Dove WF Cancer Res; 1994 Nov; 54(22):5947-52. PubMed ID: 7954427 [TBL] [Abstract][Full Text] [Related]
14. Alpha-catenin is essential in intestinal adenoma formation. Shibata H; Takano H; Ito M; Shioya H; Hirota M; Matsumoto H; Kakudo Y; Ishioka C; Akiyama T; Kanegae Y; Saito I; Noda T Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18199-204. PubMed ID: 17989230 [TBL] [Abstract][Full Text] [Related]
15. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia. Silverman KA; Koratkar R; Siracusa LD; Buchberg AM Genome Res; 2002 Jan; 12(1):88-97. PubMed ID: 11779834 [TBL] [Abstract][Full Text] [Related]
16. A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice. Shoemaker AR; Moser AR; Midgley CA; Clipson L; Newton MA; Dove WF Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10826-31. PubMed ID: 9724789 [TBL] [Abstract][Full Text] [Related]
17. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms. Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720 [TBL] [Abstract][Full Text] [Related]
18. Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc(+) allele. Andreassen A ; Vikse R; Steffensen IL; Paulsen JE; Alexander J Mutagenesis; 2001 Jul; 16(4):309-15. PubMed ID: 11420398 [TBL] [Abstract][Full Text] [Related]
19. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. Moser AR; Dove WF; Roth KA; Gordon JI J Cell Biol; 1992 Mar; 116(6):1517-26. PubMed ID: 1541640 [TBL] [Abstract][Full Text] [Related]